Pharma & Biotech

The seventh edition of this report provides an overview of the life sciences research tools (LSRT) market from 2019 to 2027. LSRT companies offer instruments, reagents and services to academic, biopharma, applied market, and (non-IVD) clinical customers. While the LSRT space includes hundreds of companies, the market is relatively consolidated, with top vendors including Agilent, Becton Dickinson, Danaher, Illumina, Merck-EMD Millipore, and (most notably) Thermo Fisher representing the majority of sales; however, mid-size players (e.g., PacBio) and smaller emerging players (e.g., Element) are often growing more rapidly, and driving innovation.

This report provides a summary of the current spatial biology market landscape, as well as a forward-looking perspective of the spatial biology market from 2024 to 2029.

The second edition of DeciBio's Clinical Oncology Biomarker Testing Market Report provides a summary of the current clinical oncology predictive and prognostic testing market landscape, as well as a forward-looking perspective of the market through 2028. Content includes a rigorous assessment of market size and growth, as well as key drivers, moderators, and trends related to predictive and prognostic biomarker testing in solid tumors.

DeciBio conducted 10 interviews with medical oncologists and biopharma executives to understand how minimal residual disease (MRD) testing and ctDNA monitoring are currently integrated into solid tumor care